PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification.

Abstract

Authors

• Pengping Li
  Department of Thyroid & Breast Surgery, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang, China.
• Wei Wang
  State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, China.
• Shaowen Wang
  Department of Geography and Geographic Information Science, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
• Guodong Cao
  The Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
• Tonghe Pan
  The Department of Ningbo Eye Hospital, Affiliated to Wenzhou Medical University, Ningbo, Zhejiang, China.
• Yuqing Huang
  Department of Thoracic Surgery, Beijing Haidian Hospital, Beijing, China.
• Hong Wan
  School of Electrical Engineering, Zhengzhou University, Zhengzhou, Henan, China; Industrial Technology Research Institute, Zhengzhou University, Zhengzhou, Henan, China; Henan Key Laboratory of Brain Science and Brain-Computer Interface Technology, Zhengzhou, Henan, China. Electronic address: wanhong@zzu.edu.cn.
• Weijun Zhang
  Shanghai United Imaging Healthcare Co., Ltd., Shanghai, China.
• Yate Huang
  School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China.
• Haigang Jin
  Department of Thyroid & Breast Surgery, The First People's Hospital of Xiaoshan District, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang, China.
• Zhenyu Wang
  Department of Radiology, Affiliated Hospital 6 of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, China.

Keywords

External Resources